Plecanatide, Plecanatide API, Plecanatide Peptide, Peptide
GMP FDA COA
467426-54-6
Pharmaceutical Grade
99%
Chengdu
Chengdu Shengnuo, Shengnuo Biopharm
g
2025-11-16
Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1
-
Product Description
-
Seller Information
-
History Price
-
DescriptionECHEMI Editorial ReferencePlecanatide is an oral guanylate cyclase-C agonist that is being developed by Synergy Pharmaceuticals for the treatment of gastrointestinal disorders, such as chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C). It is a synthetic analogue of human uroguanylin, a 16 amino acid peptide that regulates ion and fluid transport in the gastrointestinal tract. In January 2017, plecanatide received its first global approval in the USA for the treatment of adult patients with CIC. Plecanatide is undergoing phase III investigation in IBS-C.Research & Reference Note
Plecanatide, Plecanatide API, Plecanatide Peptide, Peptide is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
CertificatesBasic Info-
Product Name:
Plecanatide
Other Name:Plecanatide;ASN-ASP-GLU-CYS-GLU-LEU-CYS-VAL-ASN-VAL-ALA-CYS-THR-GLY-CYS-LEU(DISULFIDE BOND CYS1&CYS3,CYS2&CYS4);Plecanatide Impurtiy;L-Leucine, L-asparaginyl-L-α-aspartyl-L-α-glutamyl-L-cysteinyl-L-α-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (4→12),(7→15)-bis(disulfide);Plecanatide impurity;Plecanatide USP/EP/BP;Prikanatide;ATCH(1-39)
CAS No.:467426-54-6
Molecular Formula:C65H104N18O26S4
InChIKeys:NSPHQWLKCGGCQR-DLJDZFDSSA-N
Molecular Weight:1681.89
Color/Form:White to off-white
Categories:
Characteristics-
Density:
1.47±0.1 g/cm3(Predicted)
Boiling Point:2120.0±65.0 °C(Predicted)
PKA:3.61±0.21(Predicted)
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Semaglutide API,Tirzepatide API,Liraglutide API,Linaclotide API,Creatine Monohydrate,Copper Tripeptide-1
-
Location:
Chengdu Shengnuo Biopharm Co., Ltd.
-
Payment Terms:
TT against copy of documents,D/P,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
365 days
-
Total Annual Revenue:
Above $100 million
-
Total Employees:
Above 1000
-
Year of Establishment:
2004
-
-
Weekly Price
The chart shows the price trend of the product in the past 12 months.
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Octreotide Acetate, Octreotide Acetate API, Octreotide Acetate Peptide
Pharmaceutical Grade / 99%
-
-
-
-
Cagrilintide, Cagrilintide API, Cagrilintide Peptide, Peptide
Pharmaceutical Grade / 99%
-
-
-
-
Tirzepatide, Tirzepatide API, GLP-1, GLP-1 API, Peptide, Peptide API
Pharmaceutical Grade / 99%
-
-
-
-
Retatrutide, LY3437943, Retatrutide API, Retatrutide Peptide, Peptide, GLP-1
Pharmaceutical Grade / 99%
-